| MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment CD Verrico, GM Miller, BK Madras Psychopharmacology 189, 489-503, 2007 | 232 | 2007 |
| A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain CD Verrico, S Wesson, V Konduri, CJ Hofferek, J Vazquez-Perez, E Blair, ... Pain 161 (9), 2191-2202, 2020 | 160 | 2020 |
| Primate trace amine receptor 1 modulation by the dopamine transporter GM Miller, CD Verrico, A Jassen, M Konar, H Yang, H Panas, M Bahn, ... Journal of Pharmacology and Experimental Therapeutics 313 (3), 983-994, 2005 | 124 | 2005 |
| Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: comparison of schizophrenia and major depressive disorder SM Eggan, SR Stoyak, CD Verrico, DA Lewis Neuropsychopharmacology 35 (10), 2060-2071, 2010 | 121 | 2010 |
| Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats CD Verrico, JD Jentsch, RH Roth Synapse 49 (1), 61-66, 2003 | 91 | 2003 |
| Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization TP George, CD Verrico, MR Picciotto, RH Roth Journal of Pharmacology and Experimental Therapeutics 295 (1), 58-66, 2000 | 89 | 2000 |
| Repeated exposure to Δ9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat JD Jentsch, CD Verrico, D Le, RH Roth Neuroscience letters 246 (3), 169-172, 1998 | 89 | 1998 |
| A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders JJ Mahoney III, DGY Thompson-Lake, K Cooper, CD Verrico, TF Newton, ... Journal of psychopharmacology 29 (1), 50-56, 2015 | 78 | 2015 |
| Repeated Δ9-Tetrahydrocannabinol Exposure in Adolescent Monkeys: Persistent Effects Selective for Spatial Working Memory CD Verrico, H Gu, ML Peterson, AR Sampson, DA Lewis American Journal of Psychiatry 171 (4), 416-425, 2014 | 75 | 2014 |
| Psychosis and synthetic cannabinoids H Deng, CD Verrico, TR Kosten, DA Nielsen Psychiatry Research 268, 400-412, 2018 | 67 | 2018 |
| Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats JD Jentsch, L Dazzi, JP Chhatwal, CD Verrico, RH Roth Neuroscience letters 258 (3), 175-178, 1998 | 67 | 1998 |
| Repeated, intermittent Δ9-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention CD Verrico, JD Jentsch, RH Roth, JR Taylor Neuropsychopharmacology 29 (3), 522-529, 2004 | 56 | 2004 |
| The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders JJ Mahoney III, R De La Garza II, BJ Jackson, CD Verrico, A Ho, T Iqbal, ... Psychiatry research 219 (2), 367-371, 2014 | 53 | 2014 |
| Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress TP George, CD Verrico, RH Roth Brain research 801 (1-2), 36-49, 1998 | 49 | 1998 |
| Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial C Rodgman, CD Verrico, M Holst, D Thompson-Lake, CN Haile, ... The Journal of clinical psychiatry 77 (5), 4895, 2016 | 45 | 2016 |
| Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study CD Verrico, CN Haile, JJ Mahoney III, DGY Thompson-Lake, TF Newton, ... Drug and alcohol dependence 141, 72-78, 2014 | 44 | 2014 |
| Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: evidence for opioid mechanisms TP George, CD Verrico, L Xu, RH Roth Neuropsychopharmacology 23 (1), 79-88, 2000 | 44 | 2000 |
| Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications CD Verrico, CN Haile, TF Newton, TR Kosten, R De La Garza Expert opinion on investigational drugs 22 (12), 1549-1568, 2013 | 42 | 2013 |
| Endocannabinoid metabolism in the prefrontal cortex in schizophrenia DW Volk, BI Siegel, CD Verrico, DA Lewis Schizophrenia research 147 (1), 53-57, 2013 | 39 | 2013 |
| Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat CD Verrico, JD Jentsch, L Dazzi, RH Roth Synapse 48 (4), 178-183, 2003 | 36 | 2003 |
